Lexicon Pharmaceuticals, Inc.
Symbol: LXRX (NASDAQ)
1.45
▼ (-4.61%) -0.070
Company Description:
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.
Key Stats
- Today's Open: $1.454
- Today's High: $1.454
- Today's Low: $1.45
- Today's Volume: 2.99K
- Yesterday Close: $1.52
- Yesterday High: $1.53
- Yesterday Low: $1.43
- Yesterday Volume: 1.88M
- Last Min Volume: 5
- Last Min High: $1.45
- Last Min Low: $1.45
- Last Min VWAP: $1.45
Company Profile
- Name: Lexicon Pharmaceuticals, Inc.
- Website: https://www.lexpharma.com
- Listed Date: 2000-04-07
- Location: THE WOODLANDS, TX
- Market Status: Active
- CIK Number: 0001062822
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $552.37M
- Round Lot: 100
- Outstanding Shares: 363.40M
- Asset Type: CS
RECENT FILINGS FOR LXRX
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-08-06 | S-8 | View |
| 2025-08-06 | 10-Q | View |
| 2025-08-06 | 8-K | View |
| 2025-07-28 | 8-K | View |
| 2025-07-08 | SCHEDULE 13G/A | View |
| 2025-07-03 | 8-K | View |
| 2025-06-09 | 3 | View |
| 2025-06-06 | 3 | View |
| 2025-06-03 | 4 | View |
| 2025-06-03 | 4 | View |
| 2025-06-03 | 4 | View |
| 2025-06-03 | 4 | View |
| 2025-06-03 | 4 | View |
| 2025-06-03 | 4 | View |
| 2025-06-03 | 4 | View |
| 2025-06-03 | 8-K | View |
| 2025-05-14 | 10-Q | View |
| 2025-05-13 | 4 | View |
| 2025-05-13 | 4 | View |
| 2025-05-13 | 4 | View |
Latest News on LXRX